Back

The use of CRISPR for variant specificity in the genetic diagnosis of primary immunodeficiency disease (PID)

Mann, T.; Smith, A.; Spencer, S.; Thaventhiran, J.; Russell, A.

2019-10-15 immunology
10.1101/804732 bioRxiv
Show abstract

The functional validation of genetic variants of uncertain significance (VUS) found in PID patients by next-generation sequencing has traditionally been carried out in model systems that are susceptible to artefact. We use CRISPR correction of primary human T lymphocytes to demonstrate that a specific variant in an IL-6R deficient patient is causative for their condition. This methodology can be adapted and used for variant assessment of the heterogeneous genetic defects that affect T lymphocytes in PID.

Matching journals

The top 7 journals account for 50% of the predicted probability mass.

50% of probability mass above

"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.